بدائل البحث:
significant challenges » significant challenge (توسيع البحث), significant changes (توسيع البحث)
challenges decrease » challenges case (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
significant challenges » significant challenge (توسيع البحث), significant changes (توسيع البحث)
challenges decrease » challenges case (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
-
241
-
242
-
243
-
244
-
245
Predicted behavioural expression of young (orange) and old (blue) individuals that do (treatment) or do not (control) receive an immune challenge.
منشور في 2024"…<p>(a) If an immune challenge causes sickness behaviour then we expect that young and old immune-challenged individuals will decrease their population-level average behavioural expression compared with controls with old individuals decreasing their behavioural expression more than young individuals. …"
-
246
-
247
-
248
-
249
-
250
-
251
-
252
-
253
-
254
-
255
-
256
Table 2_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
منشور في 2024"…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…"
-
257
Table 1_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
منشور في 2024"…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…"
-
258
Table 3_Integration analysis of microRNAs as potential biomarkers in early-stage lung adenocarcinoma: the diagnostic and therapeutic significance of miR-183-3p.docx
منشور في 2024"…Introduction<p>Lung adenocarcinoma (LUAD) poses a significant therapeutic challenge, primarily due to delayed diagnosis and the limited efficacy of existing treatments.…"
-
259
-
260